1. 2023
  2. Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses

    Okonechnikov, K., Federico, A., Schrimpf, D., Sievers, P., Sahm, F., Koster, J., Jones, D. T. W., von Deimling, A., Pfister, S. M., Kool, M. & Korshunov, A., Dec 2023, In: Acta neuropathologica communications. 11, 1, p. 7 7.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Early adipogenesis is repressed through the newly identified FHL2-NFAT5 signaling complex

    Clemente-Olivo, M. P., Hernández-Quiles, M., Sparrius, R., van der Stoel, M. M., Janssen, V., Habibe, J. J., van den Burg, J., Jongejan, A., Alcaraz-Sobrevals, P., van Es, R., Vos, H., Kalkhoven, E. & de Vries, C. J. M., 1 Apr 2023, In: Cellular signalling. 104, 110587.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types

    TREAT NL registry and UK-Irish A-STAR Study Groups, 1 Mar 2023, In: JAAD International. 10, p. 14-24 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of autoimmunity. 135, 102984.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

    on behalf of the SysPharmPediA consortium, 1 Feb 2023, In: European journal of pharmaceutical sciences. 181, 106360.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis

    Hsiao, C-C., Engelenburg, H. J., Jongejan, A., Zhu, J., Zhang, B., Mingueneau, M., Moerland, P. D., Huitinga, I., Smolders, J. & Hamann, J. R., 20 Jan 2023, In: iScience. 26, 1, 105785.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors.

    Martens, A. W. J., Kavazović, I., Krapić, M., Pack, S. M., Arens, R., Jongejan, A., Moerland, P. D., Eldering, E., van der Windt, G. J. W., Wensveen, F. M., Peters, F. S. & Kater, A. P., 19 Jan 2023, In: Leukemia. p. 1-11 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Gut microbiome in allogeneic HCT survivors: The insults are gone but the damage lingers

    van Lier, Y. & Hazenberg, M. D., 18 Jan 2023, (E-pub ahead of print) In: British journal of haematology.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Lentigo maligna (melanoma): a systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy

    Elshot, Y. S., Tio, D. C. K. S., van Haersma-de With, A. S. E., Ouwerkerk, W. B., Zupan-Kajcovski, B., Crijns, M. B., Limpens, C. E. J. M., Klop, W. M. C., Bekkenk, M. W., Balm, A. J. M. & de Rie, M. A., 18 Jan 2023, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology.

    Research output: Contribution to journalReview articleAcademicpeer-review

  11. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

    van der Straten, L., Levin, M-D., Dinnessen, M. A. W., Visser, O., Posthuma, E. F. M., Doorduijn, J. K., Langerak, A. W., Kater, A. P. & Dinmohamed, A. G., 13 Jan 2023, In: Blood cancer journal. 13, 1, p. 15 1 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...78 Next

ID: 4522253